Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: Short term results

BMC Cancer

Volumn 9, Issue , 2009, Pages 313-

  Bertino, Giulia ^a   Occhini, Antonio ^a   Falco, Carlo E ^a   Porta, Camillo ^a   Corbella, Franco ^b   Colombo, Sara ^b   Balcet, Vittoria ^b   Morbini, Patrizia ^a   Zappoli, Federico ^b   Azzaretti, Andrea ^b   Rodolico, Giuseppe ^b   Tinelli, Carmine ^b   Benazzo, Marco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BRONCHOPNEUMONIA; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EDEMA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NECK EDEMA; ODYNOPHAGIA; RASH; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TONGUE DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG TOXICITY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 70349876271     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-313     Document Type: Article

References (34)

1. Lavertu P, Adelstein DJ, Saxton JP, Secic M, Eliachar I, Strome M, Larto MA, Wood BG. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer. An 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999, 125:142-148.
2. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000, 355:949-955.
3. Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G, Howell SB. Phase I study of highly selective supradose cisplatin infusion for advanced head and neck cancer. J Clin Oncol 1994, 12:2113-2120.
4. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Harstell WF, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Neill HB. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997, 38:263-271.
5. Robbins KT, Kumar P, Wong FSH, Harstell WF, Flick P, Palmer R, Weir AB, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000, 22:687-693. 10.1002/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W, 11002324.
6. Robbins KT, Kumar P, Harris J, McCulloch T, Cmelak A, Sofferman R, Levine P, Weisman R, Wilson W, Weymuller E, Fu K. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in multi-institutional setting: results of radiation therapy oncology group trial 9615. J Clin Oncol 2005, 23:1447-1454. 10.1200/JCO.2005.03.168, 15735120.
7. Rabbani A, Hinerman RW, Schmalfuss IM, Amdur RJ, Morris CG, Peters KR, Robbins KT, Mendenhall WM. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous carcinomas of the head and neck. Am J Clin Oncol 2007, 30:283-286. 10.1097/01.coc.0000258118.38177.74, 17551306.
8. Yoshizaki T, Wakisaka N, Murono S, Kondo S, Shimizu Y, Takanaka T, Sanada J, Terayama N, Matsui O, Furukawa M. Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for respectable advanced head and neck squamous cell carcinoma: a prospective study. Ann Otol Rhinol Laryngol 2007, 116:754-761.
9. Robbins KT, Storniolo AM, Hryniuk WM, Howell SB. "Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies. Laryngoscope 1996, 106:37-42. 10.1097/00005537-199601000-00008, 8544625.
10. Aisner J, Sinibaldi V, Eisenberger M. Carboplatin in the treatment of squamous cell head and neck cancers. Sem Oncol 1992, 19:60-65.
11. Volling P, Staar S, Achterrath W, Müller RP. Phase I/II study of simultaneous carboplatin and radiotherapy in unresectable squamous cell carcinoma of the head and neck. Sem Oncol 1992, 19:66-71.
12. de Serdio JL, Villar A, Martinez JC, Perez MD, Martin JJ, Fuentes C, Gil-Curbelo J, Artazkoz JJ, Saavedra JA. Chemotherapy as a part of each treatment fraction in a twice-a-day hyperfractionated schedule: a new chemoradiotherapy approach for advanced head and neck cancer. Head Neck 1998, 20:489-496. 10.1002/(SICI)1097-0347(199809)20:6<489::AID-HED1>3.0.CO;2-F, 9702534.
13. Benazzo M, Bernardo G, Corbella F, Danova M, Lanza L, Zappoli F, Uggetti C, Mira E. La chemioterapia intraarteriosa neo-adiuvante superselettiva con carboplatino ad alte dosi nei tumori avanzati cervico-facciali. Acta Otorhinol Ital 1996, 16:30-34.
14. Benazzo M, Caracciolo G, Zappoli F, Bernardo G, Mira E. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer. Eur Arch Otorhinolaryngol 2000, 257:279-282. 10.1007/s004050050240, 10923944.
15. Bertino G, Benazzo M, Occhini A, Gatti P, Bernardo G, Corbella F, Tinelli C, Zappoli F, Mira E. Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/orv radiotherapy for advanced head and neck cancer: single-center five-years results. BMC Cancer 2007, 7:62. 10.1186/1471-2407-7-62, 1854908, 17428336.
16. International Union Against Cancer TNM Classification of malignant tumours. 2002, New York: Wiley-Liss, Sixth.
17. International Commission on Radiation Units and Measuraments, ICRU 50 Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50, Bethesda 1993,
18. International Commission on Radiation Units and Measuraments, ICRU 62 Prescribing, Recording and Reporting Photon Beam therapy. (Supplement to ICRU Report 50), Bethesda 1999,
19. National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 3.0. , http://ctep.cancer.gov
20. Robbins KT, Storniolo M, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992, 14:364-371. 10.1002/hed.2880140505, 1399569.
21. Robbins KT, Fontanesi J, Wong FS, Vicario D, Seagren S, Kumar P, Weisman R, Pellitteri P, Thomas JR, Flick P, Palmer R, Weir AB, Kerber C, Murry T, Ferguson R, Los G, Orloff L, Howell SB. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996, 122:853-857.
22. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Harstell WF, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Neill HB. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997, 38:263-271. 10.1016/S1368-8375(01)00035-5, 9226312.
23. Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, Strottmann J, Pulmano C, Mohiuddin M. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 2001, 19:3333-3339. 10.1038/sj.bjc.6601674, 11454880.
24. Furutani K, Fuwa N, Kodaira T, Matsumoto A, Kamata M, Tachibana H, Sakahara H. Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol 2002, 38:145-152. 10.1002/hed.20107, 11854061.
25. Kovacs AF. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br J Cancer 2004, 90:1323-1328. 10.1016/S0002-9610(97)00147-5, 15054449.
26. Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengia M, Akyol F, Yucel T, Hosal S, Sozeri B. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 2005, 27:15-21. 10.1002/hed.20107, 15515158.
27. Denys D, Kumar P, Wong FS, Newman LA, Robbins KT. The predictive value of tumor regression rates chemoradiation therapy in patients with advanced head and neck squamous cella carcinoma. Am J Surg 1997, 174:561-564. 10.1097/00005537-200403000-00004, 9374238.
28. Doweck I, Robbins KT, Vieira F. Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001, 127:1315-1318.
29. Robbins KT, Doweck I, Samant S, Vieira F, Kumar P. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 2004, 114:411-417. 10.1001/archotol.131.11.965, 15091211.
30. Robbins KT, Wong FSH, Kumar P, Hartsell WF, Vieira F, Mullins B, Niell B. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:670-675. 10.1001/archotol.133.5.486, 10367925.
31. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 2005, 131:965-969. 10.1001/archotol.131.11.965, 16301367.
32. Robbins KT, Shannon K, Vieira F. Superselective neck dissection after chemoradiation. Arch Otolaryngol Head Neck Surg 2007, 133:486-489. 10.1016/S0140-6736(03)14567-9, 17520763.
33. Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Heckel HE, Mueller RP. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2001, 50:1161-1171.
34. Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003, 362:1255-1260. 10.1016/S0140-6736(03)14567-9, 14575968.